Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Ovarian Neoplasms 6Colonic Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pancreatitis, Acute Necrotizing 1Pancreatic Fistula 1Pancreatic Cyst 1Neoplasm Metastasis 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Krukenberg Tumor 1Hyperthermia 1Fallopian Tube Neoplasms 1Eye Neoplasms 1Endometrial Neoplasms 1Complex Ovarian Cyst 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Burkitt Lymphoma 1Anastomotic Leak 1Abdominal Injuries 1Abdominal Abscess 1

Interventions

Ipilimumab 16incomplete Freund's adjuvant 9Nivolumab 9sargramostim 6Temozolomide 6Dacarbazine 6montanide ISA 51 5MART-1 Antigen 5Blood Specimen Collection 5pembrolizumab 4Ranibizumab 4Melphalan 4Interleukin-2 4Carboplatin 4CTLA-4 Antigen 4Thalidomide 3Surveys and Questionnaires 3MAGEA3 protein, human 3Granulocyte-Macrophage Colony-Stimulating Factor 3AZD 6244 3sotrastaurin 2relatlimab 2gp100 Melanoma Antigen 2fludarabine phosphate 2fludarabine 2entinostat 2aflibercept 2Taxes 2Sunitinib 2Sorafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uveal Melanoma × Laparotomy × Clear all
NCT00062933 2012-08-20

A Phase II Study of Isolated Hepatic Perfusion (IHP) in Patients With Ocular Melanoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
40 enrolled
Dermatologic

Hyperthermia, Uveal Melanoma, Eye Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡